Associations of gene expression in blood with BMI and weight changes among women in the Norwegian Women and Cancer postgenome cohort

Abstract

AbstractObjectiveThis study aimed to evaluate associations between blood gene expression profiles and (1) current BMI and (2) past weight changes (WCs) among women who had never been diagnosed with cancer in the Norwegian Women and Cancer (NOWAC) postgenome cohort.MethodsThis cross‐sectional study (N = 1694) used gene expression profiles and information from three questionnaires: Q1 (baseline), Q2 (follow‐up), and Q3 (blood collection). The authors performed gene‐wise linear regression models to identify differentially expressed genes (DEGs) and functional enrichment analyses to identify their biological functions.ResultsWhen assessing BMIQ3, the study observed 2394, 769, and 768 DEGs for the obesity‐versus‐normal weight, obesity‐versus‐overweight, and overweight‐versus‐normal weight comparisons, respectively. Up to 169 DEGs were observed when investigating WCQ3‐Q1 (mean = 7 years, range = 5.5–14 years) and WCQ3‐Q2 (mean = 1 year, range = <1 month–9 years) in interaction models with BMI categories, of which 1 to 169 genes were associated with WCs and 0 to 9 were associated with interaction effects of BMI and WCs. Biological functions of BMI‐associated DEGs were linked to metabolism, erythrocytes, oxidative stress, and immune processes, whereas WC‐associated DEGs were linked to signal transduction.ConclusionsMany BMI‐associated but few WC‐associated DEGs were identified in the blood of women in Norway. The biological functions of BMI‐associated DEGs likely reflect systemic impacts of obesity, especially blood reticulocyte‐erythrocyte ratio shifts.